Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. Based in Menlo Park, CA, Transcend Medical was the first company to be spun out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend was recently acquired by Alcon, the global leader in eye care.